The 6th RNAi-Based Therapeutics Summit is advancing RNAi candidates into clinically relevant therapies, focusing on bioavailability, translation, off-target effects, and manufacturing challenges.
Topics
- Expanding the Therapeutic Potential of RNAi Drugs by Exhibiting the Next Generation of Therapies to Improve Drugging of Cancer Targets
- Utilizing RNAi & Screening Approaches to Develop Specific Drugs for More Effective Treatment of Diseases
- Achieving Stable & Efficacious siRNA Therapies by Optimizing Chemical Modifications Leading to Faster Approval
- Leveraging Protein Conjugates for Extra-Hepatic Delivery to Broaden the Disease Landscape Currently Accessed
- Delving into Novel Delivery Platforms & Strategies for Successful Delivery to the Liver & Beyond to Fast-Track More Effective Drugs through the Clinic
- Illuminating Optimal Strategies for Faster Development of Novel RNAi Platforms to Enable Arrival to Patients Sooner
- Navigating Critical Manufacturing Challenges to Improve Feasibility of RNAi Therapeutics & Allow Quicker Production